Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPAR?-independent mechanism.
Akinyeke TO, Stewart LV. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPAR?-independent mechanism. Cancer Biol Ther. 2011 Jun 15; 11(12):1046-58.